MEDIFAST INC (MED) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-28

MEDIFAST INC (MED) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-28. 3 Form 8-K material event filings were reported by MED in the last 90 days. InsiderAlpha tracks every MED SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About MEDIFAST INC (MED)

SEC CIK	0000910329

90-Day SEC Filing Activity

Form 4 filings (90d)	7
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-05-28

Recent MED Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-26	SCHLACKMAN SCOTT	Director	A — Grant or award	11.7K	$0.00	—	SEC
2026-05-26	Geary Elizabeth A.	Director	A — Grant or award	11.7K	$0.00	—	SEC
2026-05-26	Kiai Parsa	Director	A — Grant or award	7.6K	$0.00	—	SEC
2026-05-26	Thomas Andrea B	Director	A — Grant or award	11.7K	$0.00	—	SEC
2026-05-26	Kiai Parsa	Director	A — Grant or award	11.7K	$0.00	—	SEC
2026-05-26	Rose Jeffrey Matthew	Director	A — Grant or award	6.7K	$0.00	—	SEC
2026-05-26	Rose Jeffrey Matthew	Director	A — Grant or award	11.7K	$0.00	—	SEC
2026-05-11	SCHLACKMAN SCOTT	Director	P — Open-market purchase	2.5K	$12.53	$31K	SEC
2026-05-08	SCHLACKMAN SCOTT	Director	P — Open-market purchase	2.5K	$12.65	$32K	SEC
2026-03-25	Chard Daniel R	Chairman & CEO	A — Grant or award	4.8K	$0.00	—	SEC
2026-03-25	MacKenzie Jonathan Barrett	VP, Finance & CAO	F — Tax withholding / forfeiture	862	$9.59	$8K	SEC
2026-03-25	MacKenzie Jonathan Barrett	VP, Finance & CAO	A — Grant or award	10.8K	$0.00	—	SEC
2026-03-25	Maloney James P.	Chief Financial Officer	F — Tax withholding / forfeiture	3.2K	$9.59	$31K	SEC
2026-03-25	Maloney James P.	Chief Financial Officer	A — Grant or award	34.3K	$0.00	—	SEC
2026-03-25	Maloney James P.	Chief Financial Officer	A — Grant or award	1.0K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for MEDIFAST INC (MED). Updated in real time as new filings are submitted to the SEC.

Most-Active MED Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
SCHLACKMAN SCOTT	3	$63K
Rose Jeffrey Matthew	2	—
Kiai Parsa	2	—
Thomas Andrea B	1	—
Geary Elizabeth A.	1	—

Recent MED Form 8-K Material Events

2026-06-01 — Item 5.02, 9.01 [SEC]
2026-05-26 — Item 5.02, 5.07, 7.01, 9.01 [SEC]
2026-05-04 — Item 2.02, 9.01 [SEC]
2026-03-20 — Item 1.01, 5.02, 7.01, 9.01 · Leadership · neutral [SEC]
Medifast entered into a cooperation agreement with activist investor Steamboat Capital Partners on March 19, 2026, agreeing to nominate seven directors to the board at the 2026 Annual Meeting, including two Steamboat designees (Parsa Kiai and Jeffrey Rose) who will be nominated f
2026-02-17 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Medifast announced its fourth quarter and full year 2025 financial results on February 17, 2026. The 8-K filing itself contains no substantive financial data, metrics, or commentary—only a reference to an attached press release. The actual materiality depends entirely on the earn

Recent Insider Filings

2026-05-28 — Rose Jeffrey Matthew (Director)
2026-05-28 — Kiai Parsa (Director)
2026-05-28 — Thomas Andrea B (Director)
2026-05-28 — SCHLACKMAN SCOTT (Director)
2026-05-28 — Geary Elizabeth A. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MED insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

MED Insider Trading — FAQ

What is the latest insider trade for MED?: MEDIFAST INC (MED) had 7 insider filings in the last 90 days, with the most recent on 2026-05-28. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying MED stock?: 0 insider purchases of MED were filed in the last 90 days.
How many insiders are selling MED stock?: 0 insider sales of MED were filed in the last 90 days.
Where can I see MED SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every MED SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live MED dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.